HDL components isolated from CKD patients were changed by biochemical and mass spectrometry analyses, which showed reduced apoAI, apoAII, apoM, and paraoxonase level and increased serum amyloid A (SAA), apoCII, and lipoprotein-associated phospholipase A2 level [28]. The gene discussed is APOA2; the disease is chronic kidney disease.